Sion

Sion

> Mesothelioma > news-articles

Mesothelioma

News articles
Category=News articles RSS feed
1 Asbestos tumors respond to treatment [Edit]News articles
Eli Lilly & Co.'s experimental chemotherapy drug Alimta showed positive results in treating people suffering from a rare and insidious cancer caused by exposure to asbestos. Results from a clinical trial showed that patients with malignant pleural mesothelioma treated with Alimta lived longer, endured less pain and breathed easier than patients treated with standard chemotherapy. Alimta is the first drug shown to prolong the life expectancy of patients suffering from what is an especially fatal form of cancer that has been resistant to treatment. The disease results in tumors, usually caused by asbestos fibers lodged in the lung, which attach to the lung lining and chest wall.
2 Eli Lilly boosted by drug success [Edit]News articles
Researchers yesterday hailed the first effective treatment for mesothelioma, the incurable lung cancer caused by inhaling asbestos. Alimta, a new type of cancer treatment being developed by Eli Lilly, is the first treatment to significantly increase the length of survival and ameliorate the symptoms of the disease.
3 Study by Eli Lilly Co [Edit]News articles
A drug developed by Eli Lilly and Co. to treat a rare cancer linked to asbestos exposure lengthened the lives of patients who took the drug in clinical trials, researchers said Monday. The findings involving the new drug, Alimta, heartened cancer researchers because pleural mesothelioma has proven resistant to treatment and no drugs are approved in the United States to treat it. "This is an historic day. Patients and their families who deal with this disease now have a clear path forward," said Dr. Nicholas J. Vogelzang, director of University of Chicago Cancer Research Center.